Release Date: 25/10/10 12:05 Summary: Initial Director's Interest Notice - Stuart McDonald Price Sensitive: No Download Document 95.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%